AbbVie Inc.
$ABBV
Public valuation for AbbVie Inc. (ABBV). Fair value, signal, and key metrics — no sign-in required.
Current Price
$261.59
26% Undervalued
Fair Value Estimate
$331
🏛️
Mature Growth
Profitable company with steady growth
Analyst Consensus
Target: $278.86
7% higher than current
Key Metrics
Market Cap
$462.3B
Forward P/E
16.4x
Operating Margin
37.9%
Revenue Growth
10.8%
PEG Ratio
3.49
Get free watchlist alerts
Join the waitlist for valuation updates on $ABBV and the rest of your watchlist.
Join the waitlistJoin the waitlist
Stay on this page to join — no sign-in required.